← FDA Drug Approvals (Drugs@FDA)
NORGESTIMATE AND ETHINYL ESTRADIOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2015-09-09
Drug application
- FDA Application #
ANDA202132- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NORGESTIMATE AND ETHINYL ESTRADIOL
- Generic name
- Ethinyl Estradiol
- Active ingredients
- ETHINYL ESTRADIOL; NORGESTIMATE
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Discontinued
- Sponsor
- XIROMED
- First approval
- 2015-09-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown